SUBSCRIBE
SUBSCRIBE

TMX Newsfile

IN THE PRESS
Press Releases
Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products
April 20, 2026
 · 
6 min read
Press Releases
Sharp Therapeutics Corp. Announces Fourth Quarter 2025 Results, Closing of Convertible Note Offering and Adoption of Semi-Annual Reporting
April 20, 2026
 · 
7 min read
Press Releases
American Aires Provides Update on Liquidity Position, Strategic Review and Ongoing Litigation
April 20, 2026
 · 
4 min read
Press Releases
Marvel Biosciences Announces Closing of Convertible Debenture Offering
April 17, 2026
 · 
4 min read
Press Releases
OS Therapies Files New Patent Application Covering Biomarkers of the Immune Response to Listeria Monocytogenes
April 16, 2026
 · 
7 min read
Press Releases
Resverlogix Corp. Announces Filing of Annual Filings and Revocation of MCTO
April 16, 2026
 · 
2 min read
Press Releases
PharmaTher Supports Proposed U.S. Peptide Reclassification, Reinforcing the Strategic Value of Its Microneedle Patch Platforms for Peptide Delivery
April 16, 2026
 · 
8 min read
Press Releases
Envoy Medical Appoints Chas McKhann to Board of Directors
April 16, 2026
 · 
8 min read
Press Releases
Medexus Provides Business Update on GRAFAPEX (treosulfan) for Injection, Capital Allocation, and Investor Conference Participation
April 16, 2026
 · 
12 min read
Press Releases
Scryb Approves Proposed Name Change and Grant of Stock Options
April 15, 2026
 · 
3 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us